Silgan Holdings Inc. reported its third‑quarter 2025 financial results, showing net sales of $2.01 billion, up 15.1% year‑over‑year, and net income of $113.3 million, or $1.06 per diluted share.
Adjusted earnings per share for the quarter were $1.22, a 1% increase from the prior year. Adjusted EBIT rose to $198.7 million, an 18.8% increase from Q3 2024’s $167.3 million, and adjusted EBITDA grew 11% for the quarter. The Weener Packaging acquisition contributed $126.7 million in sales and $17 million in adjusted EBIT, with synergies already delivering $20 million of the $25 million target.
Silgan lowered its full‑year adjusted earnings‑per‑share guidance to $3.66–$3.76 from $3.85–$4.05, citing lower volume expectations in personal care and home‑care segments amid a consumer demand bifurcation, inflation, and muted wage growth. Full‑year adjusted EBIT is expected to rise in the mid‑teens, and free cash flow is projected at $430 million versus $391 million in 2024.
The company’s cost‑reduction program, totaling $50 million, delivered $20 million in savings in 2024 and is projected to generate an additional $30 million in 2025. Interest expense for the quarter was $50 million, an $8.1 million increase over Q3 2024.
Segment performance highlights include the Dispensing and Specialty Closures segment, which saw net sales rise 23% to $690.4 million, and the Custom Containers segment, with net sales up 1% to $160.1 million. Metal Containers experienced a 4% volume increase driven by the pet‑food market.
Management noted a $25 million headwind from volume shortfalls in dispensing and custom container businesses due to customer inventory reductions and weaker consumer demand, but emphasized ongoing integration of Weener and margin expansion across the portfolio.
Silgan continues to return capital to shareholders through share repurchases and dividends, with more than $120 million returned year‑to‑date.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.